DelveInsight's“Lennox–Gastaut syndrome Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Lennox–Gastaut syndrome, historical and forecasted ...

The first medical marijuana conference in Bordeaux, France, featuring doctors, scientists, and entrepreneurs from the UK and ...

Roche already has one Alzheimer’s candidate in its pipeline targeting tau, but has added a second via a deal with Belgian drugmaker UCB worth up to $2 billion. The Swiss pharma group is paying $ ...

Rise in prevalence of ulcerative colitis and Crohn's disease, growing awareness of the disease across the world, drives the growth of the market David Correa Allied Market Research + 1 800-792-5285 ...

AI, biotech and affordable clean energy will be the focus of an EU drive to make the bloc globally competitive and ensure it ...

An ustekinumab biosimilar to Stelara launched in France, completing its rollout across 5 major European markets and paving ...

As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth.

There are 20 cell and gene therapies on Europe's market versus 43 in the U.S. Find out more about this ecosystem.

United Commercial Bank PLC (UCB) hosted its three-day Annual Business Conclave 2025 with its branch managers from 23 to 25 January at the Rajendrapur BRAC CDM, marking the first such event in nearly ...

UCB Investment Limited has arranged the issuance of the "TBL 7th Subordinated Bond" valued at BDT 450 crore for Trust Bank PLC. The closing ceremony of this significant financial milestone was held at ...

Three players in the biosimilar space have already sparked hope for the new year, with each having big business or regulatory ...

After hours: January 29 at 5:59:12 PM EST Loading Chart for SNDX ...